As of Jan 14, 2025, the Hims & Hers Health stock's P/E ratio is 55.77. This results from the current EPS of $0.47 and stock price of $26.21.
Year | PE ratio | Change |
---|---|---|
2023 | N/A | N/A |
2022 | N/A | N/A |
2021 | N/A | N/A |
2020 | N/A | N/A |
2019 | N/A | N/A |
HIMS's PE ratio is above its peer stock NBIX.
Stock name | PE ratio | Market cap |
---|---|---|
NBIX Neurocrine Biosciences Inc | 36.14 | $14.12B |
HIMS Hims & Hers Health Inc | 55.77 | $5.73B |
NVAX Novavax Inc | N/A | $1.36B |
NVCR NovoCure Ltd | N/A | $2.84B |
The price to earnings ratio for HIMS stock as of Jan 14, 2025, stands at 55.77.
You can calculate the P/E ratio by dividing the most recent stock price by the trailing twelve months earnings per share(EPS). As of today (Jan 14, 2025), Hims & Hers Health's stock price is $26.21. The earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $0.47. Therefore, Hims & Hers Health's price to earnings ratio for today is 55.77. PE RATIO(55.77) = STOCK PRICE($26.21) / TTM EPS($0.47)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.